Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:12109920rdf:typepubmed:Citationlld:pubmed
pubmed-article:12109920lifeskim:mentionsumls-concept:C0030705lld:lifeskim
pubmed-article:12109920lifeskim:mentionsumls-concept:C0013557lld:lifeskim
pubmed-article:12109920lifeskim:mentionsumls-concept:C0087111lld:lifeskim
pubmed-article:12109920lifeskim:mentionsumls-concept:C1956346lld:lifeskim
pubmed-article:12109920lifeskim:mentionsumls-concept:C0051696lld:lifeskim
pubmed-article:12109920lifeskim:mentionsumls-concept:C0814225lld:lifeskim
pubmed-article:12109920pubmed:issue8lld:pubmed
pubmed-article:12109920pubmed:dateCreated2002-7-11lld:pubmed
pubmed-article:12109920pubmed:abstractTextTo estimate the potential savings in overall cardiovascular disease (CVD) treatment costs for the US population with coronary artery disease (CAD) resulting from the use of amlodipine.lld:pubmed
pubmed-article:12109920pubmed:languageenglld:pubmed
pubmed-article:12109920pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12109920pubmed:citationSubsetTlld:pubmed
pubmed-article:12109920pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12109920pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:12109920pubmed:statusMEDLINElld:pubmed
pubmed-article:12109920pubmed:issn1170-7690lld:pubmed
pubmed-article:12109920pubmed:authorpubmed-author:DoyleJohn JJJlld:pubmed
pubmed-article:12109920pubmed:authorpubmed-author:CascianoRoman...lld:pubmed
pubmed-article:12109920pubmed:authorpubmed-author:CascianoJulia...lld:pubmed
pubmed-article:12109920pubmed:authorpubmed-author:ArikianSteveSlld:pubmed
pubmed-article:12109920pubmed:authorpubmed-author:ChenJohnJlld:pubmed
pubmed-article:12109920pubmed:authorpubmed-author:KugelHeatherHlld:pubmed
pubmed-article:12109920pubmed:authorpubmed-author:ArochoRaulRlld:pubmed
pubmed-article:12109920pubmed:issnTypePrintlld:pubmed
pubmed-article:12109920pubmed:volume20lld:pubmed
pubmed-article:12109920pubmed:ownerNLMlld:pubmed
pubmed-article:12109920pubmed:authorsCompleteYlld:pubmed
pubmed-article:12109920pubmed:pagination553-63lld:pubmed
pubmed-article:12109920pubmed:dateRevised2007-11-15lld:pubmed
pubmed-article:12109920pubmed:meshHeadingpubmed-meshheading:12109920...lld:pubmed
pubmed-article:12109920pubmed:meshHeadingpubmed-meshheading:12109920...lld:pubmed
pubmed-article:12109920pubmed:meshHeadingpubmed-meshheading:12109920...lld:pubmed
pubmed-article:12109920pubmed:meshHeadingpubmed-meshheading:12109920...lld:pubmed
pubmed-article:12109920pubmed:meshHeadingpubmed-meshheading:12109920...lld:pubmed
pubmed-article:12109920pubmed:meshHeadingpubmed-meshheading:12109920...lld:pubmed
pubmed-article:12109920pubmed:meshHeadingpubmed-meshheading:12109920...lld:pubmed
pubmed-article:12109920pubmed:meshHeadingpubmed-meshheading:12109920...lld:pubmed
pubmed-article:12109920pubmed:meshHeadingpubmed-meshheading:12109920...lld:pubmed
pubmed-article:12109920pubmed:meshHeadingpubmed-meshheading:12109920...lld:pubmed
pubmed-article:12109920pubmed:year2002lld:pubmed
pubmed-article:12109920pubmed:articleTitleEconomic benefits of amlodipine treatment in patients with coronary artery disease.lld:pubmed
pubmed-article:12109920pubmed:affiliationThe Analytica Group, New York 10016, USA. rcasciano@theanalyticagroup.comlld:pubmed
pubmed-article:12109920pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:12109920pubmed:publicationTypeClinical Triallld:pubmed
pubmed-article:12109920pubmed:publicationTypeRandomized Controlled Triallld:pubmed
pubmed-article:12109920pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed